0985B |
Carbinoxamine, Blood |
1040B |
Cetirizine, Blood |
1040SP |
Cetirizine, Serum/Plasma |
1040U |
Cetirizine, Urine |
1190B |
Chlorpheniramine, Blood |
1190SP |
Chlorpheniramine, Serum/Plasma |
1190U |
Chlorpheniramine, Urine |
1210B |
Chlorpromazine, Blood |
1210FL |
Chlorpromazine, Fluid |
1210SP |
Chlorpromazine, Serum/Plasma |
1210TI |
Chlorpromazine, Tissue |
1210U |
Chlorpromazine, Urine |
1287B |
Clozapine and Metabolite, Blood |
1287FL |
Clozapine and Metabolite, Fluid |
1287SP |
Clozapine and Metabolite, Serum/Plasma |
1287TI |
Clozapine and Metabolite, Tissue |
1287U |
Clozapine and Metabolite, Urine |
1407B |
Cyclohexane, Blood |
1409B |
Cyclohexanone, Blood |
1409SP |
Cyclohexanone, Serum/Plasma |
1409U |
Cyclohexanone, Urine |
1410U |
Cyclohexanol, Urine |
1425B |
Cyproheptadine, Blood |
1425SP |
Cyproheptadine, Serum/Plasma |
1425U |
Cyproheptadine, Urine |
8681B |
Chlorpromazine, Blood |
9136B |
Chlorpromazine Screen, Blood |
9136SP |
Chlorpromazine Screen, Serum/Plasma |
9136U |
Chlorpromazine Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |